PMI04

PRECISION MOLECULAR

Drug Candidate

PMI04

Summary

Potential first-in-class imaging agent for
neuroinflammation/neurodegenerative diseases

Mechanism of Action

PET/SPECT ligand targeting CSF1R

Indication

PET/SPECT Tracer for neuroinflammation

Development Stage

Phase I